lamivudine has been researched along with Opportunistic Infections in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chim, B; Choun, K; Lorent, N; Lynen, L; Thai, S; van Griensven, J | 1 |
| Akdogan, A; Bayraktar, Y; Bilgen, SA; Calguneri, M; Ersoy, O; Ertenli, I; Kalyoncu, U; Karadag, O; Kiraz, S; Yonem, O | 1 |
| Lim, Z; Moses, SE; Zuckerman, MA | 1 |
| Goliath, R; Meintjes, G; Seldon, R; Wilkinson, KA; Wilkinson, RJ | 1 |
| Gillis, S; Hubert, A; Ilan, Y; Safadi, R; Shibolet, O; Shouval, D | 1 |
1 review(s) available for lamivudine and Opportunistic Infections
| Article | Year |
|---|---|
Hepatitis B virus infection: pathogenesis, reactivation and management in hematopoietic stem cell transplant recipients.
Topics: Antiviral Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Disease Management; DNA, Viral; Drug Administration Schedule; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunity, Cellular; Immunosuppression Therapy; Lamivudine; Opportunistic Infections; Transplantation Conditioning; Virus Activation; Virus Replication | 2011 |
1 trial(s) available for lamivudine and Opportunistic Infections
| Article | Year |
|---|---|
Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Lamivudine; Liver Function Tests; Male; Middle Aged; Opportunistic Infections; Treatment Outcome; Virus Activation | 2002 |
3 other study(ies) available for lamivudine and Opportunistic Infections
| Article | Year |
|---|---|
Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy.
Topics: Adult; Ambulatory Care Facilities; Anti-HIV Agents; Antitubercular Agents; Cambodia; Drug Interactions; Female; HIV; HIV Infections; Humans; Isoniazid; Lamivudine; Male; Nevirapine; Opportunistic Infections; Patient Dropouts; Retrospective Studies; Stavudine; Tuberculosis | 2015 |
Prophylactic use of lamivudine with chronic immunosuppressive therapy for rheumatologic disorders.
Topics: Adult; Aged; Biomarkers; DNA, Viral; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Lamivudine; Liver Function Tests; Male; Middle Aged; Opportunistic Infections; Retrospective Studies; Reverse Transcriptase Inhibitors; Rheumatic Diseases; Treatment Outcome; Viral Load | 2009 |
Immunological characterisation of an unmasking TB-IRIS case.
Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cyclopropanes; Cytokines; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Male; Opportunistic Infections; Stavudine; Thymic Factor, Circulating; Tuberculosis, Pulmonary | 2012 |